(Received for publication November 29, 1996) A new antibiotic, IT-62-B was isolated from the culture broth of Streptomyces sp. IT-62 by extraction with acetone and then with ethyl acetate, followed by conventional column chromatography using silica gel, Sephadex LH-20 and silica ODS. Its structure (C39H47NO15, MW769) was determined by XH, 13C NMR,MS, IR and UVspectrometric techniques to be a new member of the baumycin-group anthracyclines. It showed moderate activity against Gram-positive bacteria and had antitumor activity against various tumor cell lines. Further, antibiotic IT-62-B converted the morphology ofras-transformed NIH3T3cells and T-cells back to normal at concentrations inhibiting cell growth by 30% or more.
Research on oncogenes is proceeding rapidly. As a result of our screening for new antitumor antibiotics, we found a new anthracycline, IT-62-B (Fig. 1) , mainly in the culture mycelia of Streptomyces sp. IT-62, a new soil isolate, which can convert the morphology of ms-transformed mouse NIH3T3cells back to that of the normal cells. In this paper, we describe the taxonomic characteristics of the producing organism, fermentation, isolation, physico-chemical properties, structure elucidation and biological activities of Taxonomyof the Producing Strain
The strain IT-62 was isolated from a soil sample collected at Wulumuqi in Xinjiang Autonomous Province, China. Taxonomicproperties were determined according to the method of the International Streptomyces Project (ISP)2) by the use of the media recommended by Waksman3). Color names and hue numbers were assigned according to the "Color Harmony
Manual"4).
Microscopic observation showedthe aerial mycelium of strain IT-62 to be straight to flexuous and the mature spore chain to have 10 to 50 or more spores per chain ( Fig. 2) Sclerotia, sporangia and flagellated spores were not observed. The aerial mycelium was powdery and characteristically whitish to pale yellow or yellowish gray in color on inorganic salts -starch agar and oatmeal agar.
The vegetative mycelium exhibited a reddish-orange series of color on most of the media. Melanoid pigment was produced, and a soluble pigment was slightly orangish.
The cultural characteristics, physiological properties, and utilization of carbon sources of strain IT-62 examined according to the method of Pridham and Gottlieb5) are shown in Tables 1, 2 and 3, respectively. Bar represents 1/mi. APR. 1997 Cultures were observed during incubation at 27°C for 21 days. The chemical analysis of whole-cell hydrolysate conducted by the method of Nimura6), showed the presence of LL-diaminopimelic acid.
Based on the taxonomic properties as described above, Micrococcus luteus ATCC9341.
Isolation
The fermentation broth (40 liter) was centrifuged at 2800rpm to separate the mycelial cake from the broth fluid. The mycelial cake was extracted twice with acetone and then the extract was concentrated to a small volume to removeacetone. This concentrate wasadjusted to pH 8 and extracted twice with ethyl acetate. The ethyl acetate layer was dried with anhydrous Na2SO4and evaporated to give an oily residue. The residue was dissolved in Table 4 . Its UV-visible spectrum in MeOHsolu- C-6, 6a, 9, 10a, 1' H-8, 1' C-6a, 7, 9, 10 H-7, 5' C-6a,8,9, 10a, ll, lla, 13
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tion, and intense absorptions (1710, 1620, 1580cm x) in IR spectrum were characteristic for anthracyclines such as daunomycin. It showed a quasi-molecular ion peak aXrn/z 770 (M + H)+ by FAB-MS. The molecular formula was determined to be C39H47NO15 from high-resolution FAB-MSand 13C NMRspectra. The XHand 13C NMRdata of IT-62-B are summarized in Table 5 . These data showed the partial structure corresponding to its aglycone and aminosugar moieties to be identical with those of daunomycin or baumycins.
Furthermore, the spectra showed close similarity to those of the known anthracycline TAN-1 120, which was simultaneously isolated as a related component during this study. The COSY and HOHAHA experiments revealed the presence of an additional C5 unit in the molecule, which was assigned to be a 2,4-dihydroxyisovaleryl group. Nozaki et al.7) reported TAN-1120 to be a labile compound due to its characteristic substructure, i.e., a carbinolamine group. However, IT-62-B is considerably more stable; in addition, its proton signals at H-3' (4.61 ppm) and H-6" (4.70ppm)
were significantly shifted lower than those of TAN-1 120. These results indicate a structural change in the carbinolamine group in IT-62-B. Finally, detailed HMBC analysis proved the presence of an oxazolidine ring consisting of a nitrogen atom of daunosamine, methine carbon at C-6", and a 2,4-dihydroxyisovaleryl group, as illustrated in Fig. 3 . Observed C-H long-range coupling from H-3' to C-8"
clearly indicated the 4-oxo-oxazolidine structure. Consequently, the novel structure of IT-62-B was determined to be that shown in Fig. 1 .
Biological Characterization
The in vitro antimicrobial activity of IT-62-B was determined by a serial agar dilution method using Mueller-Hinton agar (Difco) after incubation for 18 hours at 37°C. As shown in Table 6 , IT-62-B showed activity against most of the Gram-positive bacteria tested, but no activity against Gram-negative bacteria except E. coli NIHJ. When it was tested with recombination-deficient mutants of Bacillus subtilis by the rec assay for the detection of DNA-damaging substances, the repair mutant (M-17) was more sensitive to IT-62-B than the parent strain (M-45). The cytotoxicity activity (IC50) was estimated by the dye-uptake method against P388, L1210, doxorubicin-resistant P388 leukemia cells (P388/ADR), and KB carcinoma cells in Eagle's minimal essential medium (Flow Laboratories) supplemented with 10% fetal calf serum (Gibco Laboratories, MEMFCS) at 37°C. When the cells (1~2 x 103cells/well) were exposed to the antibiotic for 3 days in 96-well multiplates, the results shown in Table  7 were obtained and compared with those ofdoxorubicin.
The cytotoxicity of IT-62-B resembled that of doxorubicin, although the cytotoxicity of IT-62-B against The MIC was determined by the serial dilution method using Mueller-Hinton agar at an inoculum of 106 cells/ml after an 18-hour incubation at 37°C. doxorubicin-resistant P388 cells is more potent than that of doxorubicin. The antitumor effect in vivo was examined by a single intraperitoneal administration to CDF! mice intraperitoneally implanted with 1 x 106 P388 cells. IT-62-B showed a significant antitumor effect of 119% (Increased Life Span) at a dose of 0.25mg/kg, whereas doxorubicin was required at 7 mg/kg for a similar effect (116% ILS). Evidence for cell morphological reversion was sought by microscopic observation of ras>-NIH3T3 cells in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated calf serum (Gibco) at 37°C and of human bladder carcinoma T-24 cells in MEMà" FCS in 5% CO2-containing humidified atomosphere in air at 37°C, according to the method described by Kanbe el al.16\ As shown in Fig. 4 , IT-62-B caused a flattening of NIH3T3cells that had been transformed by human H-ras and K-ras and that of T-24 cells. The effect was evident in almost all of the cells, as early as 2 days following exposure to IT-62-B at the concentrations inhibiting cell growth by 30%or more.
Discussion
Wehave searched for novel antitumor antibiotics from microbial metabolites that can reverse the transformed phenotype of H-ras transformants to normal, and which could also show inhibitory effects on the growth of tumor cells. In order to discover antitumor substance with selective cytotoxicity against transformed cells, we established the direct primary screening system for culture broth by using ras-transformed NIH3T3cells
and/or T-cells. As a result of screening, we isolated a novel baumycin-group anthracycline antibiotic, IT-62-B, from the culture mycelia of Streptomyces sp. IT-62 along with the already known anthracycline TAN-11207),
which was isolated as a comparative compoundIT-62-A in this study, IT-62-B inhibited moderately the growth of several tumor cell lines much like doxorubicin, as well as that of Gram-positive bacteria, but was ineffective against most of Gram-negative bacteria (Tables 6, 7) . 
